David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Cooper Companies
COO
$14.2B
| $3.76M | 0.01% |
63,400
+56,960
| +884% | +$3.48M |
|
1552
CALL
Bath & Body Works
BBWI
$3.69B
| $3.76M | 0.01% |
111,701
-39,337
| -26% | -$1.32M |
|
1553
CALL
Simon Property Group
SPG
$70.5B
| $3.75M | 0.01% |
23,300
-7,600
| -25% | -$1.21M |
|
1554
TherapeuticsMD
TXMD
$25.9M
| $3.75M | 0.01% |
14,186
+5,834
| +70% | +$1.69M |
|
|
MODN
1555
DELISTED
MODEL N, INC.
MODN
| $3.75M | 0.01% |
250,976
+37,845
| +18% | +$506K |
|
1556
Babcock & Wilcox
BW
$1.13B
| $3.75M | 0.01% |
112,473
-76,685
| -41% | -$4.71M |
|
1557
FIVE9
FIVN
$2.37B
| $3.73M | 0.01% |
156,276
-61,683
| -28% | -$1.34M |
|
1558
Charter Communications
CHTR
$18.2B
| $3.73M | 0.01% |
10,270
+8,370
| +441% | +$3.12M |
|
1559
Seacoast Banking Corp of Florida
SBCF
$3.32B
| $3.73M | 0.01% |
156,139
+27,591
| +21% | +$639K |
|
|
P
1560
PUT
DELISTED
Pandora Media Inc
P
| $3.73M | 0.01% |
484,300
-44,800
| -8% | -$385K |
|
1561
Inovio Pharmaceuticals
INO
$129M
| $3.73M | 0.01% |
48,992
+30,556
| +166% | +$2.27M |
|
1562
eHealth
EHTH
$38.8M
| $3.72M | 0.01% |
155,614
+20,331
| +15% | +$414K |
|
1563
OGE Energy
OGE
$9.68B
| $3.71M | 0.01% |
102,979
-160,498
| -61% | -$5.72M |
|
1564
Bio-Techne
TECH
$11.3B
| $3.71M | 0.01% |
122,736
+15,272
| +14% | +$453K |
|
1565
CALL
Delta Air Lines
DAL
$55.4B
| $3.7M | 0.01% |
76,800
-155,600
| -67% | -$7.76M |
|
|
SAVE
1566
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.7M | 0.01% |
+110,800
| New | +$4.43M |
|
1567
CALL
SLB Ltd
SLB
$79.9B
| $3.7M | 0.01% |
53,000
-6,800
| -11% | -$450K |
|
|
SP
1568
DELISTED
SP Plus Corporation
SP
| $3.69M | 0.01% |
93,537
+12,000
| +15% | +$422K |
|
1569
Vanda Pharmaceuticals
VNDA
$320M
| $3.69M | 0.01% |
206,293
-4,356
| -2% | -$72.9K |
|
1570
iShares Russell 2000 ETF
IWM
$81.7B
| $3.69M | 0.01% |
24,902
-1,291
| -5% | -$182K |
|
1571
Usana Health Sciences
USNA
$250M
| $3.69M | 0.01% |
63,868
+2,662
| +4% | +$157K |
|
|
LM
1572
DELISTED
Legg Mason, Inc.
LM
| $3.67M | 0.01% |
93,313
-52,698
| -36% | -$2.02M |
|
1573
CALL
Ecolab
ECL
$81.9B
| $3.67M | 0.01% |
28,500
| – | – |
|
|
TBHC
1574
DELISTED
The Brand House Collective
TBHC
| $3.66M | 0.01% |
320,425
+178,777
| +126% | +$1.83M |
|
1575
CALL
Puma Biotechnology
PBYI
$473M
| $3.64M | 0.01% |
30,400
+20,400
| +204% | +$1.9M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.